Italy slams hospital "excellence" ratings:
This article was originally published in Clinica
The Italian health ministry has slammed so-called "hospitals of excellence" ratings published by healthcare research institutes as confusing to the public and a disruptive influence on the healthcare system as a whole. Such ratings are based on "imprecise assessment methods, on a limited number of indicators and often are out of date", says the health ministry. Such data fuel the public's concerns regarding the quality of specific treatment being provided in centres that are not at the top of the ranking, it says. It believes that "such initiatives fail to respond to the needs of patients who, in the event of serious illness, are forced to resort to highly specialised treatments." The true measure of quality is the overall level of care provided, rather than the specific "impact factors" used for research purposes, it says.
You may also be interested in...
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.
The FDA has almost 30 decision dates coming up before New Year’s Eve, including nearly a dozen novel agents.